NO952171L - 3-heteroalifatyl- og 3-hetero(aryl)alifatyl-2(1H)-chinolon-derivater - Google Patents
3-heteroalifatyl- og 3-hetero(aryl)alifatyl-2(1H)-chinolon-derivaterInfo
- Publication number
- NO952171L NO952171L NO952171A NO952171A NO952171L NO 952171 L NO952171 L NO 952171L NO 952171 A NO952171 A NO 952171A NO 952171 A NO952171 A NO 952171A NO 952171 L NO952171 L NO 952171L
- Authority
- NO
- Norway
- Prior art keywords
- optionally
- amidated
- cyano
- unsubstituted
- stands
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
Abstract
3-heteroalifatyl- og 3-hetero(aryl)alifatyl-2(lH)-chinolonderivater med~ formel I. hvor restene R, R2. R3 og Ruavhengig av hverandre står for hydrogen, alifatiske hydrokarbonrester, eventuelt foretret hydroksy, eventuelt foretret og/eller oksydert merkapto, lkke-substituert eller allfatisk substituert amino, nitro, eventuelt forestret eller amidert karboksyky, cyano, eventuelt amidert sulfamoyl, halogen eller trlfluormetyl,. X står for oksy eller eventuelt oksydert tlo,. A står for en toverdig allfatisk rest og. Rstår for en ikke-substituert eller med en allfatisk eller aralifatisk hydrokarbonrest, eventuelt foretret hydroksy, eventuelt foretret og/eller oksydert merkapto, ikke-substituert eller allfatisk substituert amlno, allfatisk acyl, eventuelt forestret eller amidert karboksy, cyano, eventuelt amidert sulfamoyl, halogen og/eller trifluormetyl substituert, eventuelt delvis hydrert aryl- eller heteroarylrest, eventuelt foretret hydroksyrnety1, cyano eller eventuelt forestret eller amidert karboksy, deres tautomerer og/eller salter, har antagonistiske egenskaper overfor ek-sikatoriske aminosyrer, og kan bli anvendt som antikon-vulsive og antineurogenerative legemiddelstoffer.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH173294 | 1994-06-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO952171D0 NO952171D0 (no) | 1995-06-01 |
NO952171L true NO952171L (no) | 1995-12-04 |
Family
ID=4217306
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO952171A NO952171L (no) | 1994-06-02 | 1995-06-01 | 3-heteroalifatyl- og 3-hetero(aryl)alifatyl-2(1H)-chinolon-derivater |
Country Status (15)
Country | Link |
---|---|
US (1) | US5633379A (no) |
EP (1) | EP0685466A1 (no) |
JP (1) | JPH0841027A (no) |
KR (1) | KR960000868A (no) |
CN (1) | CN1120538A (no) |
AU (1) | AU2033695A (no) |
BR (1) | BR9502647A (no) |
CA (1) | CA2150645A1 (no) |
FI (1) | FI952650A (no) |
HU (1) | HUT72608A (no) |
IL (1) | IL113975A0 (no) |
NO (1) | NO952171L (no) |
NZ (1) | NZ272258A (no) |
RU (1) | RU95109098A (no) |
ZA (1) | ZA954507B (no) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2943725B2 (ja) | 1996-01-17 | 1999-08-30 | 大日本インキ化学工業株式会社 | キノリノン誘導体及びそれを有効成分とする抗アレルギー剤 |
DE19601782A1 (de) * | 1996-01-19 | 1997-07-24 | Merck Patent Gmbh | Chinolin-2-(1H)one |
DE69809827D1 (de) * | 1997-03-31 | 2003-01-16 | Korea Res Inst Chem Tech | Chinolinische Sulfid-Derivate als NMDA Rezeptor-Antagonisten und Verfahren zu ihrer Herstellung |
KR100301129B1 (ko) * | 1997-11-06 | 2001-11-30 | 김충섭 | 3-(치환-페닐티오)-4-하이드록시퀴놀린-2(1h)-온 유도체 및 그들의 제조방법 |
AU2002250256B2 (en) * | 2001-03-08 | 2008-04-03 | Emory University | pH-dependent NMDA receptor antagonists |
US6689791B2 (en) * | 2002-03-01 | 2004-02-10 | R. T. Alamo Ventures I, Llc | Carboxylated heterocyclic compounds and methods of synthesis |
MX2009014216A (es) * | 2007-06-29 | 2010-07-05 | Univ Emory | Antagonistas del receptor nmda para neuroproteccion. |
CN103508950B (zh) * | 2012-06-25 | 2016-04-20 | 南开大学 | 含亚胺结构的4-羟基-2-喹啉酮类化合物及其制备和应用 |
AU2015308350B2 (en) | 2014-08-29 | 2020-03-05 | Tes Pharma S.R.L. | Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase |
KR101847567B1 (ko) | 2015-12-24 | 2018-04-10 | 주식회사 포스코 | 미세하고 균일한 도금 조직을 갖는 도금 강판 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3847927A (en) * | 1972-12-20 | 1974-11-12 | Dow Chemical Co | Sulfur-containing hydroxypyridones |
US4124587A (en) * | 1976-03-01 | 1978-11-07 | Sandoz, Inc. | 4-Hydroxy-3-sulfinyl-quinolin-2(1H)-ones |
US4127574A (en) * | 1976-03-01 | 1978-11-28 | Sandoz, Inc. | 4-Hydroxy-3-sulfonyl-quinolin-2(1H)-ones |
EP0459561B1 (en) * | 1990-05-31 | 1995-09-20 | MERCK SHARP & DOHME LTD. | Dioxo-tetrahydroquinoline derivatives |
GB9022785D0 (en) * | 1990-10-19 | 1990-12-05 | Merck Sharp & Dohme | Therapeutic agents |
GB9026389D0 (en) * | 1990-12-05 | 1991-01-23 | Merck Sharp & Dohme | Therapeutic agents |
SE469368B (sv) * | 1991-10-09 | 1993-06-28 | Kabi Pharmacia Ab | Ny anvaendning av linomide foer tillverkning av laekemedel foer behandling av multiple sclerosis (ms) |
GB9125515D0 (en) * | 1991-11-29 | 1992-01-29 | Merck Sharp & Dohme | Therapeutic agents |
GB9125485D0 (en) * | 1991-11-29 | 1992-01-29 | Merck Sharp & Dohme | Therapeutic agents |
-
1995
- 1995-05-23 EP EP95810344A patent/EP0685466A1/de not_active Withdrawn
- 1995-05-26 AU AU20336/95A patent/AU2033695A/en not_active Abandoned
- 1995-05-29 RU RU95109098/04A patent/RU95109098A/ru unknown
- 1995-05-31 CA CA002150645A patent/CA2150645A1/en not_active Abandoned
- 1995-05-31 NZ NZ272258A patent/NZ272258A/en unknown
- 1995-05-31 FI FI952650A patent/FI952650A/fi not_active Application Discontinuation
- 1995-06-01 KR KR1019950014478A patent/KR960000868A/ko not_active Application Discontinuation
- 1995-06-01 ZA ZA954507A patent/ZA954507B/xx unknown
- 1995-06-01 HU HU9501598A patent/HUT72608A/hu unknown
- 1995-06-01 CN CN95106179A patent/CN1120538A/zh active Pending
- 1995-06-01 IL IL11397595A patent/IL113975A0/xx unknown
- 1995-06-01 US US08/456,358 patent/US5633379A/en not_active Expired - Fee Related
- 1995-06-01 NO NO952171A patent/NO952171L/no unknown
- 1995-06-02 BR BR9502647A patent/BR9502647A/pt not_active Application Discontinuation
- 1995-06-02 JP JP7136724A patent/JPH0841027A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
FI952650A0 (fi) | 1995-05-31 |
IL113975A0 (en) | 1995-10-31 |
KR960000868A (ko) | 1996-01-25 |
HU9501598D0 (en) | 1995-07-28 |
CA2150645A1 (en) | 1995-12-03 |
NZ272258A (en) | 1996-12-20 |
FI952650A (fi) | 1995-12-03 |
ZA954507B (en) | 1996-02-01 |
HUT72608A (en) | 1996-05-28 |
BR9502647A (pt) | 1996-04-23 |
CN1120538A (zh) | 1996-04-17 |
US5633379A (en) | 1997-05-27 |
RU95109098A (ru) | 1997-03-10 |
EP0685466A1 (de) | 1995-12-06 |
JPH0841027A (ja) | 1996-02-13 |
AU2033695A (en) | 1995-12-14 |
NO952171D0 (no) | 1995-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO952171L (no) | 3-heteroalifatyl- og 3-hetero(aryl)alifatyl-2(1H)-chinolon-derivater | |
TR200200234T2 (tr) | Tirozin Protein kinaz SYK purin türevleri inhibitörleri | |
DK1140078T3 (da) | Vaskulærskadende benzimidazolmidler | |
NO20002958L (no) | Benzamidinderivater som koagulasjonsfaktor Xa-hemmere | |
MY139102A (en) | Substituted n-aryl heterocycles, process for their preparation and their use as medicaments | |
FI952607A0 (fi) | Farmakologisesti aktiiviset pyridiinijohdannaiset ja menetelmät niiden valmistamiseksi | |
DK1216225T3 (da) | Nye aminodicarboxylsyrederivater med farmaceutiske egenskaber | |
DE60023870T2 (de) | Verfahren zur herstellung von 3-aryloxy-3-arylpropylamine und deren zwischenprodukte | |
ATE170883T1 (de) | Verfahren zur zweistufigen herstellung von wässrigen, selbstvernetzenden copolymerisatdispersionen und deren verwendung für lacke | |
WO2002081448A1 (fr) | Derive benzamidine | |
DE60317562D1 (de) | Benzofuranderivate,verfahren zu deren herstellung und zwischenprodukte davon | |
YU21401A (sh) | Tetrahidropiridoetri | |
ATE400577T1 (de) | Anellierte dihydropyrane | |
NO954975L (no) | Aromatisk substituerte w-amino-alkansyreamider og alkansyrediamider | |
AU5648496A (en) | Pyrazolo-(1,5a)pyrimidines, their preparation and their use | |
TR200003200T2 (tr) | Faktör XA'yı önleyen heterosiklik türevler. | |
DE69217071T2 (de) | Wasserlösliche Vinylacetat/Maleinsäurehalbamid-Copolymere und ihre Verwendung als Verflüssiger oder Wasserreduziermittel für wässrige Dispersionen | |
NO20080133L (no) | Azolopyridin-2-on derivater som lipase og fosfolipaseinhibitorer | |
WO2003059875A3 (en) | DERIVATIVES OF α-PHENYLTHIOCARBOXYLIC AND α-PHENYLOXY-CARBOXYLIC ACIDS USEFUL FOR THE TREATMENT OF DISEASES RESPONDING TO PPARα ACTIVATION | |
WO2002028821A3 (de) | Propionsäurederivate mit ppar-alpha aktivierenden eigenschaften. | |
IL162314A (en) | Pyridine-2,4-dicarboxylic acid diamides and pyrimidine-4,6-dicarboxylic acid diamides, processes for their preparation, pharmaceutical compositions comprising them and uses thereof | |
DE60310609D1 (de) | Verfahren zur herstellung von 2-aminomethylpyridin-derivaten | |
DE68904385D1 (de) | Thioformamidine, verfahren zu deren herstellung und deren anwendung als arzneimittel. | |
HUP0203161A2 (hu) | Benzamidinszármazékok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
EP1270662A3 (de) | Hydrokolloidzusammensetzung sowie deren Verwendung zur Herstellung redispergierbarer Beschichtungen, Filme, Folien oder Papiere |